KCNA3 and obesity disorder: As migration of pro-inflammatory macrophages into adipose tissue represents the initial step in obesity-induced inflammation and insulin resistance, our data suggest that inhibiting macrophage chemotaxis with Kv1.3 blockers could provide therapeutic benefits in MetS females without inhibiting other innate immune functions.